Ship Healthcare Holdings Inc (JP:3360)
:3360
Want to see JP:3360 full AI Analyst Report?
Top Page
Ship Healthcare Holdings
(3360)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥2,185.00
▼(-18.18% Downside)
Action:Reiterated
Date:05/14/26
The score is driven by solid underlying financial stability (deleveraging and positive free cash flow) and a reasonable valuation, but is materially weighed down by weak technical momentum with the stock trading below key moving averages and negative MACD.
Positive Factors
Improving leverage
Deleveraging to a D/E around 0.20 materially lowers financial risk and interest expense, increasing capacity to fund capex, facility builds or targeted M&A without dilutive equity. A stronger balance sheet supports durable strategic flexibility and resilience over the next several quarters.
Negative Factors
Margin compression
Declining gross margins and very thin net margins reduce operational resilience and the firm's ability to absorb input cost increases or pricing pressure. Persistent margin compression would limit reinvestment, slow margin recovery and amplify earnings sensitivity to revenue swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage
Deleveraging to a D/E around 0.20 materially lowers financial risk and interest expense, increasing capacity to fund capex, facility builds or targeted M&A without dilutive equity. A stronger balance sheet supports durable strategic flexibility and resilience over the next several quarters.
Read all positive factors
Ship Healthcare Holdings (3360) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥186.59B
Dividend Yield2.19%
Average Volume (3M)255.53K
Price to Earnings (P/E)16.6
Beta (1Y)0.60
Revenue Growth5.89%
EPS Growth-9.94%
CountryJP
Employees7,793
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)149.38
Shares Outstanding94,350,136
10 Day Avg. Volume330,690
30 Day Avg. Volume255,526
Financial Highlights & Ratios
PEG Ratio-1.65
Price to Book (P/B)1.47
Price to Sales (P/S)0.31
P/FCF Ratio12.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,900.00Price Target Upside8.59% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)187.25
Revenue Forecast (FY)¥752.40B
Ship Healthcare Holdings Business Overview & Revenue Model
Company Description
Ship Healthcare Holdings, Inc. engages in the medical, healthcare, welfare, and nursing care businesses worldwide. It operates through four segments: Total Pack Produce Business, Medical Supply Business, Lifecare Business, and Dispensing Pharmacy ...
How the Company Makes Money
Ship Healthcare Holdings generates revenue primarily through its diversified operations in the healthcare industry. The company earns income by offering consulting services for hospital planning and management, selling medical equipment and device...
Ship Healthcare Holdings Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 686.32B | 718.16B | 678.23B | 630.99B | 572.28B | 514.35B |
| Gross Profit | 66.79B | 66.70B | 66.74B | 65.61B | 60.62B | 53.64B |
| EBITDA | 31.50B | 31.58B | 32.16B | 31.88B | 28.61B | 26.23B |
| Net Income | 14.09B | 13.39B | 15.13B | 13.80B | 12.06B | 12.17B |
Balance Sheet | ||||||
| Total Assets | 367.17B | 385.11B | 381.70B | 387.56B | 381.98B | 335.07B |
| Cash, Cash Equivalents and Short-Term Investments | 80.57B | 80.57B | 77.50B | 85.07B | 80.92B | 73.90B |
| Total Debt | 31.56B | 30.37B | 39.30B | 59.87B | 76.01B | 63.41B |
| Total Liabilities | 220.75B | 232.68B | 231.42B | 245.33B | 250.86B | 212.75B |
| Stockholders Equity | 145.32B | 151.07B | 149.08B | 139.53B | 128.04B | 118.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.76B | 16.56B | 28.42B | 10.64B | 9.30B |
| Operating Cash Flow | 0.00 | 22.04B | 20.38B | 31.61B | 14.11B | 12.43B |
| Investing Cash Flow | 0.00 | -2.08B | -4.03B | -7.20B | -6.77B | -3.87B |
| Financing Cash Flow | 0.00 | -16.33B | -24.62B | -20.48B | -1.02B | -8.84B |
Ship Healthcare Holdings Technical Analysis
Negative
2670.50
Price Trends
2501.97
Negative
2529.04
Negative
2348.09
Positive
Market Momentum
-3.44
Negative
41.81
Neutral
10.35
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Negative. The current price of 2670.5 is above the 20-day moving average (MA) of 2429.49, above the 50-day MA of 2501.97, and above the 200-day MA of 2348.09, indicating a neutral trend. The MACD of -3.44 indicates Negative momentum. The RSI at 41.81 is Neutral, neither overbought nor oversold. The STOCH value of 10.35 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3360.
Ship Healthcare Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥2.84T | 22.88 | 8.98% | 1.22% | 9.24% | 16.68% | |
65 Neutral | ¥1.89T | 24.28 | 11.34% | 1.01% | 1.34% | -40.50% | |
64 Neutral | ¥186.59B | 16.64 | 9.53% | 2.19% | 5.89% | -9.94% | |
57 Neutral | ¥832.52B | 120.28 | 9.38% | 1.88% | -1.70% | -33.90% | |
54 Neutral | ¥264.46B | 18.74 | 4.38% | 2.03% | 2.47% | 164.11% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3360
Ship Healthcare Holdings
2,144.00
333.03
18.39%
JP:4543
Terumo
1,922.00
-747.50
-28.00%
JP:8086
Nipro
1,621.50
317.07
24.31%
JP:7733
Olympus
1,720.00
-128.04
-6.93%
JP:6869
Sysmex
1,335.00
-1,036.62
-43.71%
Ship Healthcare Holdings Corporate Events
Ship Healthcare Raises Year-End Dividend, Reaffirms 30% Payout Policy
May 12, 2026
Ship Healthcare Holdings has approved a year-end dividend of 60 yen per share for the fiscal year ended March 31, 2026, matching its latest forecast and slightly exceeding the previous year’s 58 yen. The planned payout, totaling 5,521 millio...
Ship Healthcare Flags Supplementary FY 2026 Results and Future Briefing
May 12, 2026
Ship Healthcare Holdings has released supplementary materials for its financial results for the fiscal year ending March 2026, providing additional context to its performance. The company also indicated that a financial results briefing, including...
Ship Healthcare lifts sales and dividends despite profit dip, eyes earnings recovery in FY 2027
May 12, 2026
Ship Healthcare Holdings reported a 5.9% rise in consolidated net sales to ¥718.2 billion for the fiscal year ended March 31, 2026, while operating profit slipped 1.2% and profit attributable to owners of the parent fell 11.5% to ¥13.4 b...
Ship Healthcare Reshapes Top Management and Board Structure
Mar 6, 2026
Ship Healthcare Holdings announced a reshuffle of its top management, with Director and Vice Chairman Kenzo Konishi becoming Representative Director effective April 1, 2026, following a change prompted by personal reasons. The move signals an adju...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.